Ex-CEO Thomas Okarma departing Geron with $1.3 million, consulting deal, stock

Former Geron Corp. President and CEO Thomas Okarma could receive up to $1.3 million, including $802,500 in severance pay, according to an agreement with the Menlo Park-based developer of stem cell treatments.